Lyra Therapeutics, Inc.股价飙升17.04% 市值涨535.28万美元

市场透视2025-06-03

北京时间2025年06月03日21时32分，Lyra Therapeutics, Inc.（LYRA.us）股票出现异动，股价大幅上涨17.04%。截至发稿，该股报23.70美元/股，成交量80.2666万股，换手率60.56%，振幅6.81%。最近的财报数据显示，该股实现营业收入183000.00美元，净利润-8.55百万美元，每股收益-6.50美元，毛利55000.00美元，市盈率-0.39倍...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2540777891?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-06-03 21:32","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2540777891","market":"us","top_or_hot":-1,"title":"Lyra Therapeutics, Inc.股价飙升17.04% 市值涨535.28万美元","media":"市场透视","content":"<div>\n<p>北京时间2025年06月03日21时32分，Lyra Therapeutics, Inc.（LYRA.us）股票出现异动，股价大幅上涨17.04%。截至发稿，该股报23.70美元/股，成交量80.2666万股，换手率60.56%，振幅6.81%。最近的财报数据显示，该股实现营业收入183000.00美元，净利润-8.55百万美元，每股收益-6.50美元，毛利55000.00美元，市盈率-0.39倍...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603213209a6f8bc71&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Lyra Therapeutics, Inc.股价飙升17.04% 市值涨535.28万美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLyra Therapeutics, Inc.股价飙升17.04% 市值涨535.28万美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-06-03 21:32 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603213209a6f8bc71&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年06月03日21时32分，Lyra Therapeutics, Inc.（LYRA.us）股票出现异动，股价大幅上涨17.04%。截至发稿，该股报23.70美元/股，成交量80.2666万股，换手率60.56%，振幅6.81%。最近的财报数据显示，该股实现营业收入183000.00美元，净利润-8.55百万美元，每股收益-6.50美元，毛利55000.00美元，市盈率-0.39倍...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603213209a6f8bc71&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603213209a6f8bc71&s=b","article_id":"2540777891","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603213209a6f8bc71&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2540777891","pubTimestamp":1748957523,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年06月03日21时32分，Lyra Therapeutics, Inc.股票出现异动，股价大幅上涨17.04%。Lyra Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.57%。Lyra Therapeutics, Inc.公司简介：Lyra Therapeutics Inc 是一家临床阶段的治疗公司，专注于开发和商业化针对患者的局部治疗的创新的药物与递送一体化解决方案。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","BK4007":"制药","BK4539":"次新股","LENZ":"Therapeutics","LYRA":"Lyra Therapeutics"},"translate_title":"Lyra Therapeutics, Inc. Stock Soars 17.04%, Market Cap Rises $5.3528 Million","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LENZ":1,"LYRA":1},"content_text":"北京时间2025年06月03日21时32分，Lyra Therapeutics, Inc.（LYRA.us）股票出现异动，股价大幅上涨17.04%。截至发稿，该股报23.70美元/股，成交量80.2666万股，换手率60.56%，振幅6.81%。最近的财报数据显示，该股实现营业收入183000.00美元，净利润-8.55百万美元，每股收益-6.50美元，毛利55000.00美元，市盈率-0.39倍。机构评级方面，在所有4家参与评级的机构中，100%的券商给予持有建议，无券商给予买入、卖出建议。Lyra Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.57%。其相关个股中，Traws Pharma, Inc.、Kiora Pharmaceuticals, Inc.、Revelation Biosciences Inc C/Wts 10/01/2027 (To Pur Com)涨幅较大，Revelation Biosciences, Inc.、Traws Pharma, Inc.、Kiora Pharmaceuticals, Inc.较为活跃，换手率分别为3419.82%、805.07%、642.72%，振幅较大的相关个股有Renovaro Inc.、Traws Pharma, Inc.、Moolec Science Sa C/Wts (To Pur Ord)，振幅分别为20.25%、16.90%、14.07%。Lyra Therapeutics, Inc.公司简介：Lyra Therapeutics Inc 是一家临床阶段的治疗公司，专注于开发和商业化针对患者的局部治疗的创新的药物与递送一体化解决方案。公司的运营和业务管理作为一个单一的运营部门，即开发针对耳、鼻、喉（ENT）疾病的靶向药物。其初步产品候选物 LYR-210 和 LYR-220 是生物可吸收聚合物基质，旨在通过简短、非侵入性、在诊所进行的操作给药，并计划持续向鼻窦通道递送药物，以治疗慢性鼻窦炎（CRS）。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2540777891","isCrawlerRequest":true}